Loading company…
Nimbus Therapeutics uses computational chemistry to develop small molecule drug candidates.
Founded in 2009, Nimbus Discovery is based in Boston, US, and was co-founded by Bruce Booth and Ramy Farid. It applies computational chemistry to drug development, with programs for metabolic diseases, cancer and immune-inflammatory disorders. In July 2021, the company raised USD 105 million from BVF Partners L.P., RA Capital Management, Atlas Venture, Access Biotechnology, Commodore Capital, Logos Capital and Surveyor Capital. Funding was intended to support clinical and preclinical research.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in